Gail Busza

Does insulin resistance influence neurodegeneration in non-diabetic Alzheimer’s subjects?

E. Frangou, D. Brooks, B. McGuinness, 2021, Alzheimer's Research & Therapy.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

E. Frangou, D. Brooks, B. McGuinness, 2019, Trials.

Evaluation of liraglutide in the treatment of Alzheimer's disease

E. Frangou, D. Brooks, B. McGuinness, 2021, Alzheimer's & Dementia.

Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

E. Frangou, D. Brooks, B. McGuinness, 2019, Trials.

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)

E. Frangou, C. Hölscher, B. McGuinness, 2020, Trials.